Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats - Wikidata - wikimedia - TriplyDB

Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats

Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats

http://www.wikidata.org/entity/Q28212065

about

sameAs

Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?Does Varicocelectomy Improve Gonadal Function in Men with Hypogonadism and Infertility? Analysis of a Prospective Study Pharmacogenetics of erectile dysfunction: navigating into uncharted waters Drugs in preclinical to phase II clinical development for the treatment of erectile dysfunction.Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.Research in pharmacotherapy for erectile dysfunction Varicocele and hypogonadism.Reversion of penile fibrosis: Current information and a new horizon.New approaches to the design and discovery of therapies to prevent erectile dysfunction.Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review Small RNA and its application in andrology and urology Gene transfer for the therapy of erectile dysfunction: progress in the 21st century.Weapons of penile smooth muscle destruction: androgen deficiency promotes accumulation of adipocytes in the corpus cavernosum.Bone marrow mesenchymal stem cells combined with minocycline improve spinal cord injury in a rat model.Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction.Therapeutic angiogenesis as a potential future treatment strategy for erectile dysfunction.Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Does regular consumption of green tea influence expression of vascular endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for vasculogenic erectile dysfunction progression.Energy restriction and exercise modulate angiopoietins and vascular endothelial growth factor expression in the cavernous tissue of high-fat diet-fed rats The relationship between hypogonadism and erectile dysfunction.Posttranslational modification of constitutive nitric oxide synthase in the penis Reduced corporal fibrosis to protect erectile function by inhibiting the Rho-kinase/LIM-kinase/cofilin pathway in the aged transgenic rat harboring human tissue kallikrein 1.Emerging gene and stem cell therapies for the treatment of erectile dysfunction.Gene therapy as future treatment of erectile dysfunction Evaluation and treatment of erectile dysfunction in the aging male: a mini-review.Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction.Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED.Emerging tools for erectile dysfunction: a role for regenerative medicine.Direct androgen regulation of PDE5 gene or the lack thereof.Vascular regenerative therapies for the treatment of erectile dysfunction: current approaches.Mesenchymal stem cell-based gene therapy for erectile dysfunction.Aging and sexual health: getting to the problem.Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction Testosterone, endothelial health, and erectile function.Transplantation of endothelial progenitor cells transfected with VEGF165 to restore erectile function in diabetic rats.VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction.Phosphorylated endothelial nitric oxide synthase mediates vascular endothelial growth factor-induced penile erection.Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage.Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency.

P2860

Q27025843-7A8C5F90-98DE-42A8-A08D-67909417A5D9 Q27495948-2E307CFA-4DCE-49A7-A626-954C1ACC003A Q28249515-E28FA4AA-5F66-48A9-A057-60E22699CE83 Q30252468-8AB7E5CA-984D-450E-B600-5A74ABEF223F Q33276072-CD517750-A984-455B-A04B-D85DD0870E9B Q33650796-1CA637C7-A9E5-4348-9906-64A5F93AA26A Q34349938-2556E45E-A6E2-4CB4-B019-9CE3E8075802 Q34502071-96F3007A-AECD-4520-B60E-BD4280B20BB0 Q34664336-E1A390E6-C518-43E0-AC26-361E97F674B3 Q35545755-67E0F255-9532-49A8-B6AB-1A81EAEDEC86 Q36207705-678ABBE8-DF31-46D7-9992-788ACA68E7FE Q36251577-80EF95DA-74AD-403E-B9D6-24FE895E9E56 Q36310656-3F82F056-4432-4543-BE3A-EF331D1D37A9 Q36359537-29AD04C4-78B2-4294-9654-336569469CDD Q36374987-57ACC998-99B5-474F-BA48-B145471C1EE2 Q36739886-1CB72394-537E-444F-9129-7C2E981BAABF Q36758130-96D833D7-C16C-43B1-93AC-7B47AEE2967B Q36861695-D14AE6FE-25D1-4651-B5C8-49EC801CA91C Q36979390-EE4E86A1-0042-49B8-B11C-DD9190EFB7DA Q37037548-D7E546A8-996B-4E5E-BCA1-F43BC6E7F15F Q37096549-C2C6FBE7-5064-492F-BD66-60DBF273424A Q37265170-4D24936A-5D7C-4E98-9E6E-DBC2270DB20C Q37581419-C50C0958-52E3-4056-9517-960E8C527283 Q37692808-6152BD58-E037-4ADB-882E-5EE587014B95 Q37775988-04B1052F-94BF-4173-A8AD-3366554BF86B Q37930859-A60FCE44-99A9-4F91-8706-E1B5A0FCBF54 Q37933090-14CDDD46-1B1B-4C0F-BCDB-828489792432 Q37972086-60326C5B-08A8-43B0-8F12-21960420B649 Q38028739-4C84D619-3AF6-409B-90BE-4F685329FD17 Q38088930-13AEFF0A-2F13-4010-A869-3DD649E9EEB2 Q38105311-6CE7F5C8-5D94-4F90-887B-27F764CC4687 Q38738066-A7BF65FE-2520-47D0-864A-42F2C5588F66 Q38738470-8B9C8C9F-F138-4DB6-AECE-4E4D8B567BF8 Q38902584-18DEA0D0-2D97-4FC6-A9BC-5EDB584C9AEE Q40549792-2F236C64-F775-4B26-ADF8-D0CB9C334FAF Q42141059-26CC1FF4-8737-44A4-81B5-7B243FAD416F Q44256449-F69E8820-3BAB-48CE-BD7A-2D83771F0716 Q44605081-F3FB6159-B17A-4361-9125-88449F5FBD31 Q45172293-3A352F0E-849E-4EB4-BE42-88DA6337786F Q45267419-217535AE-963B-4BDA-B64E-478173ACBD75

P2860

Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats

http://www.wikidata.org/entity/Q28212065

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@ast

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@en

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@nl

type

label

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@ast

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@en

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@nl

prefLabel

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@ast

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@en

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@nl

P1433

Q28212065-4032831D-1292-41BC-85E0-10CF44125BC0

P1476

Q28212065-1C778B4F-3DFD-49F0-977F-0AD3BF749736

P2093

Q28212065-449B275C-466D-44AF-90D0-328E3972ED84

Q28212065-4F6FDE0E-0A7D-48DC-A449-42AB3E3F06DC

Q28212065-5D6E2AAE-87C0-4B61-8BC8-E0E7B0BB4772

Q28212065-6429C376-89E6-42B4-BE5C-8557FCC55E3C

Q28212065-D62DEFEF-50E8-42B9-8AEA-60090D7AB4B0

P2860

Q28212065-396CACDE-6D64-47E8-9D05-E52692925641

Q28212065-49A791B9-BDF2-4E60-8AD3-0E0C35F7B2BA

Q28212065-7698DAF6-53FD-4C73-A898-6D01937F8185

Q28212065-775CBC07-FA27-4ABE-8513-7C5A5B418A2B

Q28212065-78188198-2D5B-4ACD-BB1F-7A0668C401F3

Q28212065-9B9F93B6-2FA9-4476-82AE-895CD0AAF875

Q28212065-E7ABA7AC-C46D-422B-A7AE-5390E0C4C378

Q28212065-EF29A481-6544-4307-A49C-FB435F8DFCE6

Q28212065-F8997733-C690-4282-9389-437630A424B3

Q28212065-FA800E4C-B40B-4EF1-8622-30867A029404

P2888

Q28212065-B55C4B3E-EE7F-4532-8FE6-33FBF9E51B85

P304

Q28212065-6BB6CAD6-F07B-4A40-AB58-54B98E13ABB8

P31

Q28212065-8492D460-56DE-4A51-B722-28565D3EAB52

P356

Q28212065-5AEFEAC4-EDE2-4048-B875-AF69C7BE58C5

P407

Q28212065-A8882229-6A68-42DF-A222-14A31581FF75

P433

Q28212065-0DEE0538-4396-4A3F-AD51-FB9523D8F4A9

P478

Q28212065-41C20B5A-3054-465B-834F-2D8B155522BD

P577

Q28212065-859AACB2-063D-41E8-9598-5CD9DCFA1362

P5875

Q28212065-27826523-8103-485B-BBD7-C7573E8B46BE

P6179

Q28212065-352A889A-6945-4FA5-89E7-568C70178824

P698

Q28212065-54FC46DD-0997-41A1-AFC8-36F3FD51A690

P921

Q28212065-8D5CFFBB-437B-4B89-AA7B-5C4580697173

Q28212065-B1C3CFD6-BCD4-42C4-B207-905F314B7ECC

P356

SJ.IJIR.3900943

P1433

International Journal of Impotence Research

P1476

Intracavernosal vascular endot ...... c erectile dysfunction in rats

@en

P2093

C-S Lin

http://www.w3.org/2001/XMLSchema#string

R S Rogers

http://www.w3.org/2001/XMLSchema#string

T F Lue

http://www.w3.org/2001/XMLSchema#string

T M Graziottin

http://www.w3.org/2001/XMLSchema#string

Y W Kan

http://www.w3.org/2001/XMLSchema#string

P2860

Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats

Androgenic maintenance of inflow and veno-occlusion during erection in the rat.

Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart

Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.

Methods for multiple steroid radioimmunoassay.

Ultrastructural changes in impotent penile tissue: a comparison of 65 patients.

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease.

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.

Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration.

In vivo assessment of trabecular smooth muscle tone, its application in pharmaco-cavernosometry and analysis of intracavernous pressure determinants.

P2888

sj.ijir.3900943

P304

26-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.IJIR.3900943

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10884475

http://www.w3.org/2001/XMLSchema#string

P6179

1037513761

http://www.w3.org/2001/XMLSchema#string

P698

12605238

http://www.w3.org/2001/XMLSchema#string

P921